Close up of business document on office desk. Top view of business charts and graphs of stock market. Closeup of growing financial chart.

NovaBay Pharmaceuticals, Inc. [NBY] took an upward turn with a change of 12.48%, trading at the price of $0.51 during the trading session on Thursday. The price movement in correlation with percentage of the mentioned increase can allow a valuable insight to investors. During the last trading session 2.19 million shares changed hands being bought and sold, while NovaBay Pharmaceuticals, Inc. shares have an average trading volume of 1.14M shares for that time period. NBY monthly volatility recorded 14.72%, in the meanwhile having share price volatility for the week set at 15.67%. PS value for NBY stocks is 1.21 with PB recorded at 5.05.

NovaBay Pharmaceuticals, Inc. [NYSE:NBY]: Analyst Rating and Earnings

Its stock price has been found in the range of 0.23 to 4.04. This is compared to its latest closing price of $0.45.

Keep your eyes peeled for the soon-to-be-published financial results of this company, which are expected to be made public on Wed 13 Nov (In 61 Days).

Fundamental Analysis of NovaBay Pharmaceuticals, Inc. [NBY]

Now let’s turn to look at profitability: with a current Operating Margin for NovaBay Pharmaceuticals, Inc. [NBY] sitting at -62.93 and its Gross Margin at +87.98, this company’s Net Margin is now -94.50%. These metrics indicate that this company is not generating as much profit, after accounting for expenses, compared to its market peers.

This company’s Return on Total Capital is -208.56, and its Return on Invested Capital has reached -157.50%. Its Return on Equity is -173.42, and its Return on Assets is -67.34. These metrics suggest that this NovaBay Pharmaceuticals, Inc. does a poor job of managing its assets, and likely won’t be able to provide successful business outcomes for its investors in the near term.

What about valuation? This company’s Enterprise Value to EBITDA is -1.44. The Enterprise Value to Sales for this firm is now 1.09. NovaBay Pharmaceuticals, Inc. [NBY] has a Price to Book Ratio of 2.67.

Shifting the focus to workforce efficiency, NovaBay Pharmaceuticals, Inc. [NBY] earns $178,686 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 3.47 and its Total Asset Turnover is 1.29. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 2.16 and its Current Ratio is 2.24. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

NovaBay Pharmaceuticals, Inc. [NBY] has 26.72M shares outstanding, amounting to a total market cap of $12.14M. Its stock price has been found in the range of 0.23 to 4.04. At its current price, it has moved down by -87.35% from its 52-week high, and it has moved up 123.19% from its 52-week low.

This stock’s Beta value is currently 4.94, which indicates that it is 15.67% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 33.55. This RSI score is good, suggesting this stock is neither overbought or oversold.

Conclusion: Is NovaBay Pharmaceuticals, Inc. [NBY] a Reliable Buy?

Shares of NovaBay Pharmaceuticals, Inc. [NBY], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.